Preamble

The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding biosimilar medications. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare professionals, and health policy decision-makers. We did a similar survey in 2015 and are now asking for your current views.

Question Title

* 1. To complete this survey, you must meet the following criteria:

• person who has a disease that is treated with biologic medications such as inflammatory bowel disease (Crohn’s disease or ulcerative colitis), diabetes, rheumatoid arthritis, cancer, osteoporosis, psoriasis, HIV, multiple sclerosis, or growth deficiencies, or caregiver of a person who has one of these diseases
• reside in Canada

T